HomeCTMX • NASDAQ
add
CytomX Therapeutics Inc
Previous close
$0.96
Day range
$0.93 - $1.03
Year range
$0.83 - $5.85
Market cap
74.00M USD
Avg Volume
984.10K
P/E ratio
6.09
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 33.43M | 26.71% |
Operating expense | 29.32M | 26.05% |
Net income | 5.74M | 91.71% |
Net profit margin | 17.16 | 51.32% |
Earnings per share | 0.07 | 75.00% |
EBITDA | 4.54M | 25.87% |
Effective tax rate | 1.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 117.59M | -39.42% |
Total assets | 138.98M | -37.16% |
Total liabilities | 162.43M | -40.37% |
Total equity | -23.45M | — |
Shares outstanding | 78.26M | — |
Price to book | -3.20 | — |
Return on assets | 6.89% | — |
Return on capital | -63.57% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 5.74M | 91.71% |
Cash from operations | -20.73M | -13.63% |
Cash from investing | 18.17M | 142.31% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.56M | 91.87% |
Free cash flow | -19.49M | -321.80% |
About
Founded
2008
Headquarters
Website
Employees
121
